EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Apalutamide‐Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report

Jun Furumido iD, Akihiro Yamashita, Ryo Kato, Kanta Hori

IJU Case Reports · 2026-03 · 9 (2)

DOI: 10.1002/iju5.70161 ↗

Kurz gefasst

Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 08.03.2026. Verfasst von Jun Furumido und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Asahikawa Kosei General Hospital Hokkaido Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Apalutamide (APA) is an androgen receptor signaling inhibitor widely used for metastatic hormone‐sensitive prostate cancer (mHSPC), though it can induce hypothyroidism. We report a severe case of APA‐induced hypothyroidism in a patient with a history of total thyroidectomy. Case Presentation A 65‐year‐old man receiving levothyroxine (175 μg/day) after thyroidectomy was diagnosed with mHSPC (Gleason score 4 + 4; PSA 13 904 ng/mL) with findings suggestive of cancer‐associated disseminated intravascular coagulation. Following APA initiation (240 mg/day), PSA decreased rapidly to 0.01 ng/mL. However, TSH levels rose progressively despite increasing levothyroxine to 275 μg/day. After a 4‐month follow‐up interruption, TSH reached 187.9 mIU/L. APA withdrawal led to rapid TSH improvement.

Conclusion

Careful TSH monitoring is essential during APA treatment, especially in patients with pre‐existing thyroid dysfunction or prior thyroidectomy. Appropriate levothyroxine titration and multidisciplinary collaboration are essential for the continuation of oncological therapy with APA.

Schlagwörter

Stichwörter der Autor:innen

apalutamidehypothyroidismprostate cancer

Autor:innen und Institutionen

  • Department of Urology Asahikawa Kosei General Hospital Hokkaido Japan.

ORCID-Profile: Jun Furumido

Zitieren

APA

Furumido, J., Yamashita, A., Kato, R., & Hori, K. (2026). Apalutamide‐Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report. IJU Case Reports, 9(2). https://doi.org/10.1002/iju5.70161

Vancouver

Furumido J, Yamashita A, Kato R, Hori K. Apalutamide‐Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report. IJU Case Reports. 2026;9(2). doi:10.1002/iju5.70161

BibTeX
@article{Furumido2026,
  author = {Furumido, Jun and Yamashita, Akihiro and Kato, Ryo and Hori, Kanta},
  title = {Apalutamide‐Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report},
  journal = {IJU Case Reports},
  year = {2026},
  volume = {9},
  number = {2},
  doi = {10.1002/iju5.70161}
}
Kostenlos starten →